Nan Fung Group Holdings Ltd

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 35Value: $122.6MLatest: 2025Q1

Nan Fung Group Holdings Ltd is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 35 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "RVMD",
  "ARGX",
  "ACAD",
  "ALXO",
  "MDGL",
  "RXRX",
  "BCYC",
  "MIRM",
  "TRML",
  "KYMR",
  "REPL",
  "AFMD",
  "BOLT",
  null,
  "GERN",
  "KALV",
  null,
  "RANI",
  "LAB",
  "BSLK",
  "EXEL",
  "INCY",
  "ILMN",
  "PTGX",
  "RYTM",
  "SLNO",
  null,
  "HRMY",
  "VRNA",
  "XENE",
  "ZLAB",
  "TRDA",
  null
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 35
Total Value: 122618049
Accession Number: 0001012975-25-000235
Form Type: 13F-HR
CIK: nan-fung-group-holdings
Manager Name: Nan-Fung-Group-Holdings

Data Enrichment

89% identified

31 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

35 positions • $122.6M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Harmony Biosciences Holdings, Inc.

HRMY|413197104

Shares:368.7K

Value:$12.2M

% of Portfolio:10.0% ($12.2M/$122.6M)

H5870P102

Shares:514.7K

Value:$9.8M

% of Portfolio:8.0% ($9.8M/$122.6M)

ILLUMINA, INC.

ILMN|452327109

Shares:119.2K

Value:$9.5M

% of Portfolio:7.7% ($9.5M/$122.6M)

Verona Pharma plc

VRNA|925050106

Shares:148.0K

Value:$9.4M

% of Portfolio:7.7% ($9.4M/$122.6M)

Zai Lab Ltd

ZLAB|98887Q104

Shares:253.7K

Value:$9.2M

% of Portfolio:7.5% ($9.2M/$122.6M)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:146.8K

Value:$6.6M

% of Portfolio:5.4% ($6.6M/$122.6M)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:121.4K

Value:$5.9M

% of Portfolio:4.8% ($5.9M/$122.6M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:79.7K

Value:$5.7M

% of Portfolio:4.6% ($5.7M/$122.6M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:158.6K

Value:$5.3M

% of Portfolio:4.3% ($5.3M/$122.6M)

Merus N.V.

MRUS|N5749R100

Shares:120.0K

Value:$5.1M

% of Portfolio:4.1% ($5.1M/$122.6M)

07725L102

Shares:15.7K

Value:$4.3M

% of Portfolio:3.5% ($4.3M/$122.6M)

Replimune Group, Inc.

REPL|76029N106

Shares:414.2K

Value:$4.0M

% of Portfolio:3.3% ($4.0M/$122.6M)

MADRIGAL PHARMACEUTICALS, INC.

MDGL|558868105

Shares:11.9K

Value:$3.9M

% of Portfolio:3.2% ($3.9M/$122.6M)

INCYTE CORP

INCY|45337C102

Shares:59.0K

Value:$3.6M

% of Portfolio:2.9% ($3.6M/$122.6M)

RECURSION PHARMACEUTICALS, INC.

RXRX|75629V104

Shares:664.6K

Value:$3.5M

% of Portfolio:2.9% ($3.5M/$122.6M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:227.1K

Value:$3.5M

% of Portfolio:2.8% ($3.5M/$122.6M)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:49.1K

Value:$2.6M

% of Portfolio:2.1% ($2.6M/$122.6M)

EXELIXIS, INC.

EXEL|30161Q104

Shares:64.2K

Value:$2.4M

% of Portfolio:1.9% ($2.4M/$122.6M)

GERON CORP

GERN|374163103

Shares:1.4M

Value:$2.2M

% of Portfolio:1.8% ($2.2M/$122.6M)

Ascendis Pharma A/S

ASND|04351P101

Shares:13.6K

Value:$2.1M

% of Portfolio:1.7% ($2.1M/$122.6M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Harmony Biosciences Holdings, Inc.(HRMYcusip413197104)	368.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$12.2M	10.0% ($12.2M/$122.6M)	QoQ -3.54% (-$449.8K) YoY -1.16% (-$143.8K)
(cusipH5870P102)✕	514.7K	QoQ +17.94% (+78.3K) YoY +17.94% (+78.3K)	All Managers (Combined)	$9.8M	8.0% ($9.8M/$122.6M)	QoQ +32.03% (+$2.4M) YoY +86.27% (+$4.5M)
ILLUMINA, INC.(ILMNcusip452327109)	119.2K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.5M	7.7% ($9.5M/$122.6M)	QoQ -40.62% (-$6.5M) YoY -42.22% (-$6.9M)
Verona Pharma plc(VRNAcusip925050106)	148.0K	QoQ +11.23% (+14.9K) YoY NEW(+148.0K)	All Managers (Combined)	$9.4M	7.7% ($9.4M/$122.6M)	QoQ +52.07% (+$3.2M) YoY NEW(+$9.4M)
Zai Lab Ltd(ZLABcusip98887Q104)	253.7K	QoQ +7.94% (+18.7K) YoY NEW(+253.7K)	All Managers (Combined)	$9.2M	7.5% ($9.2M/$122.6M)	QoQ +48.95% (+$3.0M) YoY NEW(+$9.2M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	146.8K	QoQ +17.10% (+21.4K) YoY +52.72% (+50.7K)	All Managers (Combined)	$6.6M	5.4% ($6.6M/$122.6M)	QoQ +27.58% (+$1.4M) YoY +173.88% (+$4.2M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	121.4K	QoQ NEW(+121.4K) YoY NEW(+121.4K)	All Managers (Combined)	$5.9M	4.8% ($5.9M/$122.6M)	QoQ NEW(+$5.9M) YoY NEW(+$5.9M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	79.7K	QoQ 0.00% (+0) YoY NEW(+79.7K)	All Managers (Combined)	$5.7M	4.6% ($5.7M/$122.6M)	QoQ +58.95% (+$2.1M) YoY NEW(+$5.7M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	158.6K	QoQ +48.67% (+51.9K) YoY +48.67% (+51.9K)	All Managers (Combined)	$5.3M	4.3% ($5.3M/$122.6M)	QoQ +27.24% (+$1.1M) YoY +15.86% (+$728.6K)
Merus N.V.(MRUScusipN5749R100)	120.0K	QoQ 0.00% (+0) YoY +34.09% (+30.5K)	All Managers (Combined)	$5.1M	4.1% ($5.1M/$122.6M)	QoQ +0.09% (+$4.8K) YoY +25.34% (+$1.0M)
(cusip07725L102)✕	15.7K	QoQ -21.37% (-4.3K) YoY -31.70% (-7.3K)	All Managers (Combined)	$4.3M	3.5% ($4.3M/$122.6M)	QoQ +15.84% (-$585.4K) YoY +18.84% (-$678.6K)
Replimune Group, Inc.(REPLcusip76029N106)	414.2K	QoQ +28.74% (+92.5K) YoY +102.13% (+209.3K)	All Managers (Combined)	$4.0M	3.3% ($4.0M/$122.6M)	QoQ +3.65% (+$142.6K) YoY +141.22% (+$2.4M)
MADRIGAL PHARMACEUTICALS, INC.(MDGLcusip558868105)	11.9K	QoQ +6.74% (+750) YoY +108.94% (+6.2K)	All Managers (Combined)	$3.9M	3.2% ($3.9M/$122.6M)	QoQ +14.58% (+$500.4K) YoY +159.16% (+$2.4M)
INCYTE CORP(INCYcusip45337C102)	59.0K	QoQ -11.93% (-8.0K) YoY -20.26% (-15.0K)	All Managers (Combined)	$3.6M	2.9% ($3.6M/$122.6M)	QoQ -22.79% (-$1.1M) YoY -15.25% (-$643.3K)
RECURSION PHARMACEUTICALS, INC.(RXRXcusip75629V104)	664.6K	QoQ 0.00% (-0) YoY NEW(+664.6K)	All Managers (Combined)	$3.5M	2.9% ($3.5M/$122.6M)	QoQ -21.74% (-$977.0K) YoY NEW(+$3.5M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	227.1K	QoQ +21.38% (-40.0K) YoY +982.05% (+206.1K)	All Managers (Combined)	$3.5M	2.8% ($3.5M/$122.6M)	QoQ -8.96% (-$340.1K) YoY +618.69% (+$3.0M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	49.1K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$2.6M	2.1% ($2.6M/$122.6M)	QoQ -5.37% (-$147.9K) YoY +22.24% (+$473.5K)
EXELIXIS, INC.(EXELcusip30161Q104)	64.2K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$2.4M	1.9% ($2.4M/$122.6M)	QoQ +10.87% (+$232.4K) YoY +55.58% (+$846.8K)
GERON CORP(GERNcusip374163103)	1.4M	QoQ 0.00% (-0) YoY +3.69% (-49.0K)	All Managers (Combined)	$2.2M	1.8% ($2.2M/$122.6M)	QoQ -55.08% (-$2.7M) YoY -50.03% (-$2.2M)
Ascendis Pharma A/S(ASNDcusip04351P101)	13.6K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$2.1M	1.7% ($2.1M/$122.6M)	QoQ +13.21% (+$247.4K) YoY +3.10% (+$63.8K)